Publications by authors named "Marie Josee Le Bris"

Article Synopsis
  • Inv(16)(p13q22) and t(16;16)(p13;q22) are key genetic markers in acute myelomonoblastic leukaemia (FAB AML-M4Eo), often linked to abnormal eosinophils and a better prognosis.
  • These genetic abnormalities typically produce a fusion gene (CBFB-MYH11), but some cases show normal karyotypes despite the presence of the fusion transcript.
  • A case study of a 32-year-old woman with AML-M4Eo revealed unusual genetic details, prompting the need for thorough investigations in patients with conflicting results between cytology and cytogenetics due to potential treatment implications.
View Article and Find Full Text PDF
Article Synopsis
  • * In a study from 2000 to 2014, translocations were found in 4.6% of patients at diagnosis and in 6.2% during follow-up, with the IG heavy locus being the most frequently involved.
  • * CLL cases with IG translocations tend to have unique cell features and a generally poor prognosis, emphasizing the need for testing and identifying these translocations to tailor treatment strategies effectively.
View Article and Find Full Text PDF
Article Synopsis
  • - The EVI1 gene, found on chromosome 3q26, is crucial for regulating the self-renewal of hematopoietic (blood-forming) stem cells and is linked to myeloid leukemia as a key oncogene.
  • - Overexpression of EVI1 is linked to a lack of response to chemotherapy, leading to poor patient outcomes, particularly in cases of acute myeloid leukemia and the blastic phase of chronic myeloid leukemia.
  • - Various chromosomal rearrangements, such as inv(3)(q21q26) and t(3;3)(q21;q26), are known to cause EVI1 overexpression, but many details regarding these rearrangements and their gene partners remain
View Article and Find Full Text PDF

Several chromosomal rearrangements involving band 3q26 are known to induce EVI1 overexpression. They include inv(3)(q21q26), t(3;3)(q21;q26), t(3;21)(q26;q22) and t(3;12)(q26;p13). Translocations involving the short arm of chromosome 2 and 3q26 have been reported in more than 50 patients with myeloid disorders.

View Article and Find Full Text PDF
Article Synopsis
  • Secondary acute lymphoblastic leukemia (sALL) occurs in 2-10% of ALL cases and can develop after chemotherapy or radiotherapy for prior cancers, as seen in a 72-year-old woman whose sALL followed treatment for lymphoma.
  • Genetic analysis revealed specific chromosomal rearrangements, particularly a fusion of the MLL and PRRC1 genes, which is a significant finding in the diagnosis of sALL.
  • A review of 65 sALL cases showed many were linked to the MLL rearrangement, with a high correlation to patients having received topoisomerase II inhibitors during their initial cancer treatments, suggesting a potential cause for the secondary leukemia.
View Article and Find Full Text PDF
Article Synopsis
  • Structural abnormalities on chromosome 7q are commonly found in chronic B-cell lymphoproliferative disorders, specifically involving the CDK6 gene due to translocations.
  • Three notable translocations (t(7;14), t(7;22), and t(2;7)) have been identified that enhance the expression of CDK6 by positioning it near immunoglobulin gene enhancers during B-cell development.
  • Recent studies have linked these genetic rearrangements to lymphoproliferative malignancies in patients, showing that increased CDK6 expression can affect the cell cycle, particularly the G1 phase and G1/S transition.
View Article and Find Full Text PDF
Article Synopsis
  • * These genes require protein interactions to function properly and play a critical role in balancing cell growth and differentiation.
  • * Dysregulation of HOX genes is linked to leukemia, often caused by chromosomal changes or mutations, and understanding their mechanisms could help in creating new treatments.
View Article and Find Full Text PDF
Article Synopsis
  • * The occurrence of a double inversion on both chromosome 3s is rare, with only eight known cases, and recent findings include two new patient cases.
  • * The genetic analysis showed that while the inversion breakpoints were different between the two patients, the regions affected were similar, suggesting a possible shared mechanism behind the double inversions.
View Article and Find Full Text PDF
Article Synopsis
  • - The couple had a 4-year struggle with infertility, and the man was diagnosed with oligoasthenozoospermia (low sperm count and motility).
  • - Genetic testing revealed an unusual chromosome (supernumerary marker chromosome) related to chromosome 22 and a 15.6% chance of sperm carrying this abnormality.
  • - Despite the potential genetic risks, the couple chose not to undergo prenatal testing and successfully welcomed a healthy baby through Intracytoplasmic Sperm Injection (ICSI).
View Article and Find Full Text PDF
Article Synopsis
  • Chromosomal rearrangements involving the MLL gene at 11q23 can lead to fusion transcripts with over 60 other genes, including the recurrent MLL/AFF1 fusion found in pre-B acute lymphoblastic leukemia (ALL).
  • A gene expression profiling study of four adult ALL patients revealed significant differences when compared to patients with another fusion gene, ABL1, identifying 477 differentially expressed genes.
  • While various studies report different expression profiles due to varying methodologies, results indicate that t(4;11)(q21;q23)-associated ALL may involve distinct biological pathways, suggesting it could represent different types of leukemia.
View Article and Find Full Text PDF

Translocations involving band 12p13 are one of the most commonly observed chromosomal abnormalities in human leukemia and myelodysplastic syndrome. Their frequently result in rearrangements of the ETV6 gene. At present, 48 chromosomal bands have been identified to be involved in ETV6 translocations, insertions or inversions and 30 ETV6 partner genes have been molecularly characterized.

View Article and Find Full Text PDF

Inv(3)(q21q26)/t(3;3)(q21;q26) is recognized as a distinctive entity of acute myeloid leukemia (AML) with recurrent genetic abnormalities of prognostic significance. It occurs in 1-2.5% of AML and is also observed in myelodysplastic syndromes and in the blastic phase of chronic myeloid leukemia.

View Article and Find Full Text PDF

Chromosomal rearrangements involving the MLL gene have been associated with many different types of hematological malignancies. Fluorescent in situ hybridization with a panel of probes coupled with long distance inverse-PCR was used to identify chromosomal rearrangements involving the MLL gene. Between 1995 and 2010, 27 patients with an acute leukemia were found to have a fusion gene involving MLL.

View Article and Find Full Text PDF

We report here three children with a der(11)t(11;16), two sibs (patients 1 and 2) having inherited a recombinant chromosome from a maternal t(11;16)(q24.3;q23.2) and a third unrelated child with a de novo der(11)t(11;16)(q25;q22.

View Article and Find Full Text PDF

Cytogenetic abnormalities identified by conventional cytogenetics (CC) have important prognostic and therapeutic roles in myelodysplastic syndromes (MDS). Fluorescence in situ hybridization (FISH) complements CC since it is able to evaluate large numbers of interphase and metaphase nuclei. The question has been raised as to whether interphase FISH in addition to CC is able to imprive the level of detection of del(5q) and del(20q) in MDS.

View Article and Find Full Text PDF

The development of the bacterial artificial chromosome (BAC) system was driven in part by the human genome project in order to construct genomic DNA libraries and physical maps for genomic sequencing. The availability of BAC clones has become a valuable tool for identifying cancer genes. We report here our experience in identifying genes located at breakpoints of chromosomal rearrangements and in defining the size and boundaries of deletions in hematological diseases.

View Article and Find Full Text PDF

The RUNX1 gene, located in chromosome 21q22, is crucial for the establishment of definitive hematopoiesis and the generation of hematopoietic stem cells in the embryo. It contains a 'Runt homology domain' as well as transcription activation and inhibition domains. RUNX1 can act as activator or repressor of target gene expression depending upon the large number of transcription factors, coactivators and corepressors that interact with it.

View Article and Find Full Text PDF

We report the case of a 74-year-old man who sought care for de novo myelodysplastic syndrome (RAEB-1). Conventional cytogenetic techniques showed a karyotype with two different deletions of the long arm of chromosome 5 distributed in three clones: 46,XY,del(1)(p34),del(5)(q14q23)[2]/46,XY,del(1)(p34),del(5)(q14q34)[10]/46,idem,inv(5)(q?11q?34)[7]. Precise characterization of the breakpoints, delineation of the deleted regions, identification of the complex intrachromosomal rearrangement of chromosome 5, and sequential accumulation of chromosomal abnormalities were elucidated by several fluorescence in situ hybridization analyses.

View Article and Find Full Text PDF

We report twins for whom ultrasound examinations revealed a Turner syndrome in the female fetus and a normal male fetus. A selective pregnancy termination was decided on the female fetus with hydrops. The death of both twins called in question the chorionic diagnosis.

View Article and Find Full Text PDF